HT3 Investimentos

cvc

HT3 Investimentos is the corporate venture capital (CVC) arm of the H. Egídio Group, a Brazilian pharma-hospital conglomerate. It invests in healthtech and related sectors, as demonstrated by leading a R$10 million investment round in Central da Visão, a healthtech that provides affordable ophthalmic surgeries. The firm focuses on Brazilian and potentially broader LATAM markets, backing early to growth-stage companies in the healthcare space.